Susan Philip

Recommended Articles

• 5 Tips On Living with HIV

  HIV, which stands for human immunodeficiency virus, is an infection that attacks the human being's defense system. When the infection gets into the body, it slowly destroys the immune system, leaving the body weak to various infections. As the virus continues to stay in the body, it develops from...

• Psych Disorders Often Precede Lupus Diagnosis

  Classical lupus with typical malar rash and other well-known symptoms is extremely rare. This autoimmune ailment may start insidiously in some and may develop gradually in others. In some, it may begin as a renal problem, or heart disease, while in others various psychiatric issues may precede the...

• Massachusetts Company Cannot Fire Worker for Using Medical Marijuana in Crohn’s Disease Management

  The potential legalization of marijuana has been a "hot topic" for some years now, as certain states make moves for legalization and even more have approved the use of medical marijuana. However, not all employers necessarily condone those who work for them using the drug, even for medical purposes....

• What are Hot Flashes?

  Hot flashes are a sensation of warmth that is often followed by sweating, particularly in the neck and the face. These are normally seen in women who are permenopausal or in the menopausal stage. Hot flashes result in a flushed face and mostly occurs in the night. Some women report to have chills...

• Beyond the Basics of Crohn's: Anal Fistulas

  Crohn’s disease can affect the digestive tract, all the way from the mouth to the anus. It is understandable that most people with Crohn’s do not wish to speak about one of the most common and painful symptoms associated with Crohn’s disease: anal fistulas. Most avoid the subject because they...

• Breaking News on the Treatment of Follicular Lymphoma

  Reuters, the international news agency out of London, has announced that the FDA has given a new drug “accelerated approval,” for the treatment of follicular lymphoma.The drug, Aliqopa (copanlisib), showed complete or partial shrinkage of tumors in 59% of study participants during drug studies,...